Despite the lack of response to gap junction inhibitors, the correlation between the levels of Cx43 expression and the spectrum of malignancy of prostate cancer cell lines strongly suggests a critical role of Cx43 in prostate cancer progression. The gene discussed is GJA1; the disease is Familial prostate cancer.